Literature DB >> 22817655

Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study.

J-C Luo1, H-B Leu, M-C Hou, C-C Huang, H-C Lin, F-Y Lee, F-Y Chang, W-L Chan, S-J Lin, J-W Chen.   

Abstract

BACKGROUND: Few large population-based studies have compared the occurrence of peptic ulcer bleeding (PUB) in cirrhotic and noncirrhotic patients. AIMS: To investigate if cirrhotic patients have higher risk of PUB than the general population and to identify possible risk factors of PUB in cirrhotic patients.
METHODS: Using the National Health Insurance Research Database, a nationwide population-based dataset in Taiwan and matching age, gender, comorbidities and ulcerogenic medication by propensity score, 4013 cirrhotic patients, 8013 chronic hepatitis patients and 7793 normal controls were compared. The log-rank test was used to analyse differences in accumulated PUB-free survival rates between the groups. Cox proportional hazard regressions were performed to evaluate independent risk factors for PUB in all patients and identified risk factors of PUB in cirrhotic patients.
RESULTS: During the 7-year follow-up, cirrhotic patients had significantly higher incidences of PUB than chronic hepatitis patients and controls, respectively (P < 0.001 by log-rank test). By Cox proportional hazard regression analysis, cirrhosis was independently associated with increased risk of PUB (hazard ratio: 4.22; 95% CI 3.37-5.29, P < 0.001) after adjusting for age, gender, economic status, underlying comorbidities and ulcerogenic medication. Age, male, diabetes, chronic renal disease, history of gastro-oesophageal variceal bleeding and use of nonsteroidal anti-inflammatory drugs were risk factors for PUB in cirrhotic patients.
CONCLUSION: Cirrhotic patients have a significantly higher risk of peptic ulcer bleeding after adjustments for possible confounding factors like age, gender, economic status, underlying comorbidities and ulcerogenic medication.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22817655     DOI: 10.1111/j.1365-2036.2012.05225.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  23 in total

1.  Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Should patients presenting with peptic ulcer bleed be screened to rule out cirrhosis of the liver?

Authors:  Ansul Gupta; Anil C Anand
Journal:  Indian J Gastroenterol       Date:  2016-11

3.  Cirrhosis and gastrointestinal bleeding.

Authors:  Shih-Wei Lai; Kuan-Fu Liao
Journal:  Dig Dis Sci       Date:  2012-10-21       Impact factor: 3.199

Review 4.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

5.  Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis.

Authors:  Kuang-Wei Huang; Hsin-Bang Leu; Jiing-Chyuan Luo; Wan-Leong Chan; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Yi-Chun Kuan
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.199

Review 6.  Bacterial infections in cirrhosis: A critical review and practical guidance.

Authors:  Chalermrat Bunchorntavakul; Naichaya Chamroonkul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2016-02-28

Review 7.  Gastrointestinal dysfunction in liver cirrhosis.

Authors:  Evangelos Kalaitzakis
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 8.  Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia.

Authors:  Katsunori Iijima; Takeshi Kanno; Tomoyuki Koike; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

9.  Risk of hepato-biliary cancer after cholecystectomy: a nationwide cohort study.

Authors:  Wei-Yu Kao; Chian-Yaw Hwang; Chien-Wei Su; Yun-Ting Chang; Jiing-Chyuan Luo; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu
Journal:  J Gastrointest Surg       Date:  2012-11-27       Impact factor: 3.452

Review 10.  Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens.

Authors:  Shen-Shong Chang; Hsiao-Yun Hu
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.